Viewing Study NCT01440361


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2025-12-29 @ 2:07 PM
Study NCT ID: NCT01440361
Status: WITHDRAWN
Last Update Posted: 2014-07-28
First Post: 2011-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-03
Start Date Type: None
Primary Completion Date: 2015-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2015-04
Completion Date Type: ESTIMATED
First Submit Date: 2011-09-22
First Submit QC Date: None
Study First Post Date: 2011-09-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-24
Last Update Post Date: 2014-07-28
Last Update Post Date Type: ESTIMATED